Auxilium Pharma likely poised for solid Xiaflex launch, says Collins Stewart
Collins Stewart's survey of U.S.-based surgeons indicates that Auxilium's Xiaflex will perform well following its expected launch in the U.S. The firm expects Xiaflex to launch in the U.S. next quarter and it maintains a Buy rating on the stock. :theflyonthewall.com
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
There are 9 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.